Your browser doesn't support javascript.
loading
The recency ratio assessed by story recall is associated with cerebrospinal fluid levels of neurodegeneration biomarkers.
Bruno, Davide; Jauregi Zinkunegi, Ainara; Kollmorgen, Gwendlyn; Suridjan, Ivonne; Wild, Norbert; Carlsson, Cynthia; Bendlin, Barbara; Okonkwo, Ozioma; Chin, Nathaniel; Hermann, Bruce P; Asthana, Sanjay; Zetterberg, Henrik; Blennow, Kaj; Langhough, Rebecca; Johnson, Sterling C; Mueller, Kimberly D.
Affiliation
  • Bruno D; School of Psychology, Liverpool John Moores University, UK. Electronic address: d.bruno@ljmu.ac.uk.
  • Jauregi Zinkunegi A; School of Psychology, Liverpool John Moores University, UK.
  • Kollmorgen G; Roche Diagnostics GmbH, Penzberg, Germany.
  • Suridjan I; Roche Diagnostics International Ltd, Rotkreuz, Switzerland.
  • Wild N; Roche Diagnostics GmbH, Penzberg, Germany.
  • Carlsson C; Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Department of Medicine, University of
  • Bendlin B; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.
  • Okonkwo O; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.
  • Chin N; Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA.
  • Hermann BP; Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Department of Neurology, University of Wisconsin - Madison, Madison, WI, USA.
  • Asthana S; Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA.
  • Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institut
  • Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Langhough R; Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Department of Medicine, University of
  • Johnson SC; Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Department of Medicine, University of
  • Mueller KD; Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA; Department of Communication Sciences a
Cortex ; 159: 167-174, 2023 02.
Article in En | MEDLINE | ID: mdl-36630749

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease / Cognitive Dysfunction Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cortex Year: 2023 Document type: Article Country of publication: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease / Cognitive Dysfunction Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cortex Year: 2023 Document type: Article Country of publication: Italy